A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Submitted |
---|---|
Submitter | Belgium |
Regulatory programme |
|
Classification
Proposed harmonised classification by the dossier submitter |
|
---|
Intention timeline
Date of intention | 2019-01-28 |
---|---|
Expected date of submission | 2019-03-15 |
Submitted for accordance check | 2019-03-07 |
Documents
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
April 4, 2019
- Regulatory programme: Other substance → Chemical registered under REACH
Nov. 26, 2019
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/7e671d29-5cc7-0fdf-290e-c60390a21d42
- CLH report: https://echa.europa.eu/documents/10162/fb4e709c-ec65-70d9-23de-cfdf6a17c8d4
- Deadline for commenting: 2020-01-24
- Final submission date: 2019-10-24
- Hazard classes open for commenting: Reproductive toxicity Specific target organ toxicity – repeated exposure
- Legal deadline for opinion adoption: 2021-04-24
- Status: Submitted → Public Consultation
- Start of consultation: 2019-11-25
Jan. 24, 2020
- Status: Public Consultation → Opinion Development
Feb. 4, 2020
- Comments received: https://echa.europa.eu/documents/10162/69bc3295-3fd8-90de-5419-1e25f0683f9c
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/e173b449-a119-3edc-33e0-b96e2f3a8d10
March 16, 2020
- Submitter email: Reach@health.fgov.be
Jan. 19, 2021
- Date of opinion: 2020-12-10
- Status: Opinion Development → Opinion Adopted
Feb. 18, 2021
- Background document: https://echa.europa.eu/documents/10162/b9bc1431-1d1d-1528-6ada-9bb3d9e26c0c
- Comments received: https://echa.europa.eu/documents/10162/69bc3295-3fd8-90de-5419-1e25f0683f9c → https://echa.europa.eu/documents/10162/8419da1f-d2c0-1d5f-4ff9-a464ec61ae65
- RAC opinion: https://echa.europa.eu/documents/10162/a51f690e-7865-9476-c9b2-a7144073af72
Jan. 18, 2023
- ATP number and date: ATP18 - (16/02/2022), 23/11/2023
- Link to ATP / File Title: Official Journal
- Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0692&qid=1667995782196
This version
March 14, 2019
- Proposed harmonised classification by the dossier submitter: Repr. 1B, H360D
- Proposed harmonised classification by the dossier submitter: STOT RE 1, H372
- Status: Intention → Submitted
- Submitted for accordance check: 2019-03-07
Add the related substance to your watchlist to monitor this regulatory record.